HNRNPK and liver cancer: Procedures such as ChIRP-MS reveal remarkable collaboration, such as MaTAR25-Tensin1 in breast cancer, m6A-modified TP53TG1-CIP2A in gastric cancer, and CRLM1-hnRNPK in liver cancer [57,58].